Metabolomic analysis reveals differences in urinary excretion of kiwifruit-derived metabolites in a mouse model of inflammatory bowel disease

Molecular Nutrition and Food Research

Volumn 55, Issue 12, 2011, Pages 1900-1904

  Lin, Hui Ming ^a,b,c   Edmunds, Shelley J ^b,c,d   Zhu, Shuotun ^a   Helsby, Nuala A ^a   Ferguson, Lynnette R ^a,c   Rowan, Daryl D ^b,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

^c Nutrigenomics New Zealand   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Inflammatory bowel disease; Interleukien 10 deficient mouse; Interleukin 10; Kiwifruit; Metabolomics

Indexed keywords

ANTIINFLAMMATORY AGENT; INTERLEUKIN 10; PLANT EXTRACT;

ACTINIDIA; ANIMAL; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; ENTERITIS; FRUIT; FUNCTIONAL FOOD; GENOTYPE; MALE; METABOLOME; METABOLOMICS; MOUSE; MOUSE MUTANT; NOTE; PATHOLOGY; URINE;

ACTINIDIA; ANIMALS; ANTI-INFLAMMATORY AGENTS; DISEASE MODELS, ANIMAL; FRUIT; FUNCTIONAL FOOD; GENOTYPE; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; MALE; METABOLOME; METABOLOMICS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLANT EXTRACTS;

EID: 82955161698     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100302     Document Type: Note

References (25)

1. Baumgart, D. C., Carding, S. R., Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369, 1627-1640.
2. Dupont, B., Dupont, C., Justum, A. M., Piquet, M. A. et al., Enteral nutrition in adult Crohn's disease: present status and perspectives. Mol. Nutr. Food Res. 2008, 52, 875-884.
3. Shapiro, H., Singer, P., Halpern, Z., Bruck, R., Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis. Gut 2007, 56, 426-435.
4. Whiting, C. V., Bland, P. W., Tarlton, J. F., Dietary n-3 polyunsaturated fatty acids reduce disease and colonic proinflammatory cytokines in a mouse model of colitis. Inflamm. Bowel Dis. 2005, 11, 340-349.
5. Fiorentino, A., D'Abrosca, B., Pacifico, S., Mastellone, C. et al., Identification and assessment of antioxidant capacity of phytochemicals from kiwi fruits. J. Agric. Food Chem. 2009, 57, 4148-4155.
6. Scalbert, A., Johnson, I. T., Saltmarsh, M., Polyphenols: antioxidants and beyond. Am. J. Clin. Nutr. 2005, 81, 215S-217S.
7. Philpott, M., Mackay, L., Ferguson, L. R., Forbes, D. et al., Cell culture models in developing nutrigenomics foods for inflammatory bowel disease. Mutat. Res. 2007, 622, 94-102.
8. Edmunds, S. J., Roy, N. C., Love, D. R., Laing, W. A., Kiwifruit extracts inhibit cytokine production by lipopolysaccaride-activated macrophages and intestinal epitheal cells isolated from IL10 gene deficient mice. Cell. Immunol. 2011, 270, 70-79.
9. Scalbert, A., Brennan, L., Fiehn, O., Hankemeier, T. et al., Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics 2009, 5, 435-458.
10. Lin, H. M., Barnett, M. P., Roy, N.C., Joyce, N. I. et al., Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's disease. J. Proteome Res. 2010, 9, 1965-1975.
11. Sellon, R.K., Tonkonogy, S., Schultz, M., Dieleman, L. A. et al., Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 1998, 66, 5224-5231.
12. Roy, N., Barnett, M., Knoch, B., Dommels, Y. et al., Nutrigenomics applied to an animal model of inflammatory bowel diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutat. Res. 2007, 622, 103-116.
13. Phipps, A. N., Stewart, J., Wright, B., Wilson, I. D., Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica 1998, 28, 527-537.
14. Gonthier, M. P., Verny, M. A., Besson, C., Remesy, C. et al., Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J. Nutr. 2003, 133, 1853-1859.
15. Bolivar, V. J., Cook, M. N., Flaherty, L., Mapping of quantitative trait loci with knockout/congenic strains. Genome Res. 2001, 11, 1549-1552.
16. -/- mice using Short-Column LCMS metabolomics. J. Biomed. Biotechnol. 2011, 974701.
17. Madsen, K. L., Malfair, D., Gray, D., Doyle, J. S. et al., Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm. Bowel Dis. 1999, 5, 262-270.
18. Konishi, Y., Hitomi, Y., Yoshioka, E., Intestinal absorption of p-coumaric and gallic acids in rats after oral administration. J. Agric. Food Chem. 2004, 52, 2527-2532.
19. Thibault, R., De Coppet, P., Daly, K., Bourreille, A. et al., Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. Gastroenterology 2007, 133, 1916-1927.
20. Lupp, C., Robertson, M. L., Wickham, M. E., Sekirov, I. et al., Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007, 2, 119-129.
21. Bowey, E., Adlercreutz, H., Rowland, I., Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem. Toxicol. 2003, 41, 631-636.
22. Bibiloni, R., Simon, M. A., Albright, C., Sartor, B. et al., Analysis of the large bowel microbiota of colitic mice using PCR/DGGE. Lett. Appl. Microbiol. 2005, 41, 45-51.
23. Mankertz, J., Schulzke, J. D., Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr. Opin. Gastroenterol. 2007, 23, 379-383.
24. Sokol, H., Lay, C., Seksik, P., Tannock, G.W., Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflamm. Bowel Dis. 2008, 14, 858-867.
25. Wilson, I. D., Nicholson, J. K., The role of gut microbiota in drug response. Curr. Pharm. Des. 2009, 15, 1519-1523.